*Some Market data delayed by 15 mins.

Lineage Cell Therapeutics, Inc.

Symbol: LCTX (NYSE)
1.22 ▲ (19.12%) 0.195

Company Description:
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Key Stats
  • Today's Open: $1.03
  • Today's High: $1.305
  • Today's Low: $1.021
  • Today's Volume: 7.42M
  • Yesterday Close: $1.02
  • Yesterday High: $1.0488
  • Yesterday Low: $1
  • Yesterday Volume: 838.28K
  • Last Min Volume: 1.24K
  • Last Min High: $1.215
  • Last Min Low: $1.215
  • Last Min VWAP: $1.215
Company Profile
  • Name: Lineage Cell Therapeutics, Inc.
  • Website: https://www.lineagecell.com
  • Listed Date: 1992-03-05
  • Location: CARLSBAD, CA
  • Market Status: Active
  • CIK Number: 0000876343
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $274.03M
  • Round Lot: 100
  • Outstanding Shares: 228.36M
  • Asset Type: CS
RECENT FILINGS FOR LCTX
Filing Date Filing Type Format
2025-08-15 S-8 View
2025-08-12 10-Q View
2025-08-12 8-K View
2025-07-17 SCHEDULE 13G/A View
2025-07-03 4 View
2025-07-02 4 View
2025-07-02 4 View
2025-07-02 4 View
2025-07-02 4 View
2025-07-02 4 View
2025-07-02 8-K View
2025-06-23 8-K View
2025-06-11 DEFA14A View
2025-06-09 8-K View
2025-05-13 10-Q View
2025-05-13 8-K View
2025-05-01 8-K View
2025-04-29 ARS View
2025-04-29 DEFA14A View
2025-04-29 DEF 14A View
Latest News on LCTX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.